Governor Kathy Hochul announced Thursday that Regeneron Pharmaceuticals, a global leader in biotechnology founded in New York State, will create 1,000 new jobs ...

Regeneron Pharmaceuticals is acquiring "substantially all" of 23andMe's assets for $256 million following a bankruptcy auction. The drugmaker is buying 23andMe's Personal Genome Service, Total Health ...

Regeneron has settled its patent dispute with Celltrion, giving the go-ahead for another biosimilar to its blockbuster eye drug Eylea (aflibercept) to hit the U.S. market in just over a year. The deal ...

Regeneron has given up on a CAR-T candidate acquired from 2seventy bio last year, before it entered the second part of a phase 1/2 lymphoma study. The dual-targeting CAR-T, dubbed bbT369, was being ...

TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Tuesday reported third-quarter net income of $1.46 billion. On a per-share basis, the Tarrytown, New York-based ...

Names, credit-card details and Social Security numbers are the currency of the dark net. Now, your DNA may be, too. Ancestry-tracing company 23andMe is offering five years of genetic-monitoring ...